Scientists have progressed from merely provoking an anti-cancer immune response to designing it ...

Recent research has focused on the role of the IL-2 receptor in acute allograft rejection. T-cell proliferation, a central event leading to graft rejection, is triggered by the interaction of IL-2 ...

is a novel CD8+ T cell selective IL-2, generated by fusing a reduced potency IL-2 mutein to an anti-CD8β antibody. It was specifically engineered to selectively and potently activate CD8+ T-cells ...

Coya Therapeutics (COYA) announced encouraging blood biomarker data from an investigator-initiated, 21-week, double-blind, placebo-controlled, ...